HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,849-1,860 of 4,505
Drug study icon
CompletedEUCTR 2012-003805-86

A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Latvia
SchizophreniaHistorical research record
Countries
Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedEUCTR 2012-002785-12

A 28-week, randomised, open-label study evaluating the effectiveness of aripiprazole once-monthly versus paliperidone palmitate in adult patients with schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
SchizophreniaHistorical research record
Countries
United Kingdom, Czechia, Estonia, + 4 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2015-004835-10

A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients with Schizophrenia Previously Stabilized on the Pa...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Croatia
SchizophreniaHistorical research record
Countries
United Kingdom, Croatia, Denmark, + 5 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2010-022181-28

A 6-month, randomised, double-blind, parallel-group, risperidone-controlled, fixed-dose study evaluating the safety and efficacy of zicronapine in patients with schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
SchizophreniaHistorical research record
Countries
Czechia, Estonia, Finland, + 1 other
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2007-004482-18

A blinded-initiation study of medication satisfaction in subjects with schizophrenia treated with paliperidone ER after suboptimal response to oral risperidone.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
SchizophreniaHistorical research record
Countries
Czechia, Slovakia
Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.